Posted inGastroenterology news Oncology
New International Consensus: Colorectal Cancer Risk in MASLD — What Clinicians Need to Know
An international Delphi panel concludes metabolic dysfunction‑associated steatotic liver disease (MASLD) raises colorectal cancer (CRC) risk. Experts call for earlier, risk‑adapted CRC screening and integrated metabolic care to reduce CRC burden in patients with MASLD.